Michael Goodwin
Impact in
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Tuberculosis Research and Epidemiology 10
-
- Phenothiazines and Benzothiazines Synthesis and Activities 4
- Cancer therapeutics and mechanisms 4
- Biochemical and Molecular Research 3
- Co-authors
- Clifton E. Barry (14 shared papers)Helena I. Boshoff (11 shared papers)Uwe Sauer (1 shared paper)Shinya Watanabe (1 shared paper)Michael Zimmermann (1 shared paper)Ujjini H. Manjunatha (5 shared papers)Cynthia S. Dowd (6 shared papers)Thomas H. Keller (4 shared papers)
- Journals
- Journal of Medicinal Chemistry (5 papers)Antimicrobial Agents and Chemotherapy (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)Rapid Communications in Mass Spectrometry (1 paper)PLoS Biology (1 paper)
- Partner nations
- United StatesUnited KingdomSouth Africa
In The Last Decade
Michael Goodwin
14 papers receiving 601 citations
Peers
Comparison fields: 5 of 67
- Infectious Diseases 391
- Molecular Medicine 63
- Epidemiology 215
- Organic Chemistry 155
- Molecular Biology 295
Countries citing papers authored by Michael Goodwin
This map shows the geographic impact of Michael Goodwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Goodwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Goodwin more than expected).
Fields of papers citing papers by Michael Goodwin
This network shows the impact of papers produced by Michael Goodwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Goodwin. The network helps show where Michael Goodwin may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Goodwin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 196 | |
| 2 | 2012 | 98 | |
| 3 | 2005 | 74 | |
| 4 | 2009 | 72 | |
| 5 | 2008 | 60 | |
| 6 | 2011 | 37 | |
| 7 | 2018 | 30 | |
| 8 | 2021 | 14 | |
| 9 | 2021 | 11 | |
| 10 | 2019 | 9 | |
| 11 | 2004 | 8 | |
| 12 | 2006 | 6 | |
| 13 | 2024 | 1 | |
| 14 | 2009 | 1 |
About Michael Goodwin
Michael Goodwin is a scholar working on Infectious Diseases, Molecular Biology, Organic Chemistry, Epidemiology and Surgery, having authored 14 papers that have together received 617 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (10 papers), Phenothiazines and Benzothiazines Synthesis and Activities (4 papers), Mycobacterium research and diagnosis (4 papers), Cancer therapeutics and mechanisms (4 papers), Biochemical and Molecular Research (3 papers), Synthesis and Characterization of Heterocyclic Compounds (2 papers), Microbial Natural Products and Biosynthesis (2 papers) and Synthesis and biological activity (2 papers). The work is most often cited by research in Infectious Diseases (391 citations), Molecular Medicine (63 citations), Epidemiology (215 citations), Organic Chemistry (155 citations) and Molecular Biology (295 citations). Michael Goodwin has collaborated with scholars based in United States, United Kingdom and South Africa. Frequent co-authors include Clifton E. Barry, Helena I. Boshoff, Uwe Sauer, Shinya Watanabe, Michael Zimmermann, Ujjini H. Manjunatha, Cynthia S. Dowd, Thomas H. Keller, Véronique Dartois and Laura E. Via. Their work appears in journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy, Bioorganic & Medicinal Chemistry Letters, Rapid Communications in Mass Spectrometry and PLoS Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.